Steven Lichtman analyst OPPENHEIMER

Currently out of the existing stock ratings of Steven Lichtman, 110 are a BUY (88.71%), 14 are a HOLD (11.29%).

Steven Lichtman

Work Performance Price Targets & Ratings Chart

Analyst Steven Lichtman works at OPPENHEIMER with a stock forecast success ratio of 60.58% fulfilled within 162.68 days on average.

Steven Lichtman’s has documented 271 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BWAY, Brainsway Ltd at 09-May-2024.

Wall Street Analyst Steven Lichtman

Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 2/27/2019. The price target of $68 was fulfilled within 2 days with a profit of $6.14 (9.93%) receiving and performance score of 49.63.

Average potential price target upside

BSX Boston Scientific Corp DXCM DexCom ELGX Endologix GKOS Glaukos Corp GMED Globus Medical IART Integra LifeSciences Holdings MDT Medtronic PLC ORGO Organogenesis Holdings PODD Insulet SYK Stryker TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings ALC Alcon AG CFMS ConforMIS COO The Cooper Companies . Common Stock MMSI Merit Medical Systems MNKD MannKind Corp BWAY Brainsway Ltd RXST Rxsight MODD Modular Medical

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

90

$15.35 (20.56%)

85

3 days ago

3/6 (50%)

$15.55 (20.89%)

110

Buy

78

$3.35 (4.49%)

60

22 days ago

14/15 (93.33%)

$4.83 (6.60%)

513

Hold

73

$-1.65 (-2.21%)

55

23 days ago

4/4 (100%)

$-0.26 (-0.35%)

77

Buy

82

$7.35 (9.85%)

72

23 days ago

3/4 (75%)

$8.74 (11.93%)

560

Buy

85

$10.35 (13.86%)

73

23 days ago

17/18 (94.44%)

$11.74 (16.03%)

346

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Steven Lichtman is most bullish on?

Potential upside of $34.82 has been obtained for ZBH (ZIMMER BIOMET HOLDINGS)

Which stock is Steven Lichtman is most reserved on?

Potential downside of -$6.65 has been obtained for BSX (BOSTON SCIENTIFIC CORP)

What Year was the first public recommendation made by Steven Lichtman?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?